Aditxt Inc. (NASDAQ:ADTX) shares traded 6.16% higher at $1.55 on Wall Street last session.
In accordance with the data, 2 analysts cover Aditxt Inc. (NASDAQ:ADTX). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $4.00 and a low of $4.00, we find $4.00. Given the previous closing price of $1.46, this indicates a potential upside of 173.97 percent. ADTX stock price is now 0.84% away from the 50-day moving average and -79.58% away from the 200-day moving average. The market capitalization of the company currently stands at $6.04M.
Will You Miss Out On This Growth Stock Boom?
A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.
And this is just one of our
5 Best Growth Stocks To Own For 2023.
Sponsored
It has been rated a hold by 1 analysts and a buy by 1. Brokers who have rated the stock have averaged $4.00 as their price target over the next twelve months.
.
In other news, Albanna Amro A., Chief Executive Officer bought 1 shares of the company’s stock on Jul 19. The stock was bought for $20,000 at an average price of $20000.00. Upon completion of the transaction, the Chief Executive Officer now directly owns 1 shares in the company, valued at $1.55. A total of 1.16% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in ADTX stock. A new stake in Aditxt Inc. shares was purchased by SABBY MANAGEMENT, LLC during the first quarter worth $269,000. BANK OF NEW YORK MELLON CORP invested $54,000 in shares of ADTX during the first quarter. In total, there are 24 active investors with 16.30% ownership of the company’s stock.
Aditxt Inc. (NASDAQ: ADTX) opened at $1.4500 on Monday. During the past 12 months, Aditxt Inc. has had a low of $1.00 and a high of $28.49. As of last week, the company has a debt-to-equity ratio of 0.02, a current ratio of 2.90, and a quick ratio of 2.60. The fifty day moving average price for ADTX is $1.5372 and a two-hundred day moving average price translates $7.5902 for the stock.
The latest earnings results from Aditxt Inc. (NASDAQ: ADTX) was released for Jun, 2022. According to the Biotechnology Company, earnings per share came in at -$6.5, missing analysts’ expectations of $5.5 by -12. This compares to -$28.08 EPS in the same period last year. For the current quarter, analysts expect ADTX to generate $350k in revenue.
Aditxt Inc.(ADTX) Company Profile
Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its own tissues. The company is also developing ADi products for organ transplantation, including skin grafting, autoimmune diseases, and allergies. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia.
